Immix Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	19.69	17.51	13.44	17.64	0.39	0.73
Cash & Short-Term Investments	19.69	17.51	13.44	17.64	0.39	0.73
Cash Growth	0.55%	30.31%	-23.85%	4411.66%	-46.72%	-
Other Receivables	1.98	1.17	0.26	0.03	0.13	0.18
Receivables	1.98	1.17	0.26	0.03	0.13	0.18
Prepaid Expenses	1.05	1.06	1.13	0.52	0.01	0.02
Other Current Assets	0.04	0.04	0.08	-	-	-
Total Current Assets	22.76	19.79	14.9	18.19	0.53	0.93
Property, Plant & Equipment	2.37	0.05	0	0.01	0.01	0.01
Long-Term Deferred Charges	-	0.09	0.01	-	-	-
Total Assets	25.14	19.93	14.91	18.19	0.54	0.94
Accounts Payable	3.29	1.43	0.14	0.14	0.25	0.25
Accrued Expenses	3.21	2.29	1.13	0.01	0.34	0.24
Short-Term Debt	-	-	-	0.05	0.05	4.1
Current Portion of Long-Term Debt	-	-	-	-	4.05	-
Other Current Liabilities	-	-	-	-	0.58	-
Total Current Liabilities	6.56	3.72	1.27	0.2	5.27	4.59
Other Long-Term Liabilities	-	-	0.48	-	-	-
Total Liabilities	7.59	3.72	1.75	0.2	5.27	4.59
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	87.67	69.78	51.16	47.62	0.51	0.51
Retained Earnings	-70.21	-53.41	-37.99	-29.76	-5.37	-4.22
Treasury Stock	-0.1	-0.1	-0.1	-	-	-
Comprehensive Income & Other	0.19	0.13	0.09	0.13	0.13	0.07
Total Common Equity	17.55	16.41	13.16	17.99	-4.73	-3.65
Minority Interest	-	-0.2	-	-	-	-
Shareholders' Equity	17.55	16.2	13.16	17.99	-4.73	-3.65
Total Liabilities & Equity	25.14	19.93	14.91	18.19	0.54	0.94
Total Debt	1.09	-	-	0.05	4.1	4.1
Net Cash (Debt)	18.6	17.51	13.44	17.59	-3.71	-3.37
Net Cash Growth	-5.01%	30.31%	-23.63%	-	-	-
Net Cash Per Share	0.71	1.01	0.97	4.79	-1.10	-1.00
Filing Date Shares Outstanding	27.51	26.4	13.9	13.86	3.38	3.38
Total Common Shares Outstanding	27.48	19.92	13.89	13.23	3.38	3.38
Working Capital	16.19	16.07	13.62	17.98	-4.74	-3.66
Book Value Per Share	0.64	0.82	0.95	1.36	-1.40	-1.08
Tangible Book Value	17.55	16.41	13.16	17.99	-4.73	-3.65
Tangible Book Value Per Share	0.64	0.82	0.95	1.36	-1.40	-1.08

Source: S&P Capital IQ. Standard template. Financial Sources.